Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXO7NO
|
||||
| Drug Name |
benzyl-(7,8-dimethoxy-10,11-dihydro-5H-2,4,5,11-tetraaza-dibenzo[a,d]cyclohepten-1-yl)-amine
|
||||
| Synonyms |
CHEMBL215191
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H21N5O2
|
||||
| Canonical SMILES |
COc1cc2CNc3c(NCc4ccccc4)ncnc3Nc2cc1OC
|
||||
| InChI |
InChI=1S/C20H21N5O2/c1-26-16-8-14-11-21-18-19(22-10-13-6-4-3-5-7-13)23-12-24-20(18)25-15(14)9-17(16)27-2/h3-9,12,21H,10-11H2,1-2H3,(H2,22,23,24,25)
|
||||
| InChIKey |
SLYLBACSXAVTAA-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Epidermal growth factor receptor III | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.